Ciclad acquires a stake in Groupe Phen’X Technologies, a specialist in the machining of precision parts for the medical sector, through an LBO. This primary LBO is also an opportunity for managers Manuel Gomes and Christophe Roy to involve the director of the Portuguese industrial site in the capital.
This operation will enable the group to continue its internationalization and operational structuring. Created in 2011 by its founders, who have over 30 years’ experience in micro-medical machining, the Phen’X Technologies group specializes in the industrialization of medical devices (co-design and manufacturing), particularly for dental, maxillofacial and orthopedic surgery. With 2 production sites located in France and Portugal, the group also holds ISO 13485:2016 certification and is a registered Contract Manufacturer with the FDA (US). With around 60 employees, Phen’X Technologies expects to generate sales of €8 million by 2024.
Thomas Deborne, Senior Business Manager – Ciclad: “We’re delighted to complete this transaction and to be associated with the management team. Their expertise and strategic vision will be invaluable assets for the success of this new phase of growth. This collaboration will enable us to develop our international business while maintaining Phen’X Technologies’ outstanding operational performance.”
